Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/1996
01/03/1996EP0587790B1 Non-chlorofluorocarbon aerosol formulations
01/03/1996EP0553130B1 Pyrrolidine dione derivatives
01/03/1996EP0513104B1 USE OF AN alpha-tocoPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED
01/03/1996EP0505377B1 Muscarinic receptor antagonists
01/03/1996EP0502169B1 Piperazine derivatives
01/03/1996EP0462292B1 Salt eliminant composition
01/03/1996EP0401262B1 24r-scymnol, and preparation and use thereof
01/03/1996CN1114506A Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
01/03/1996CN1114319A 1,9-bridged thiazolo(3,2-A)quinoline derivatives
01/03/1996CN1114318A Novel purine derivatives and pharmaceutically acceptable salts thereof
01/03/1996CN1114312A Sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation, and their use as pharmaceuticals
01/03/1996CN1114311A Process for preparing 4-pyridylmethyl amine derivatives
01/03/1996CN1114310A 1H-indole-3-glyoxylamide spla2 inhibitors
01/03/1996CN1114207A Immunopotentiator for curing disease caused by toxic reaction of excessive free radicals
01/03/1996CN1114192A Injection for curing optic atrophy and preparing process thereof
01/03/1996CN1114191A Medicine for curing skin disease
01/03/1996CN1114190A Mixed treating liquid of high molecular synthetic material for double-fold eyelid operation
01/03/1996CN1114189A Erythromycin capsule for silkworm
01/03/1996CN1114180A Cosmetic or pharmaceutical composition for topical use
01/03/1996CN1030611C Method for preparing a novel stable form II diritromycin
01/03/1996CN1030610C Crystalline etoposide 4'-phosphate diethanolate
01/03/1996CN1030609C Methylenebisphosphonic acid derivatives
01/03/1996CN1030608C Method of preparation for N-(pyrroloÛ2,3-dÙ pyrimidin-3-ylacyl)-glutamic acid derivatives
01/03/1996CN1030605C 4-substituted phrazolo|3,4-d¨ pyrimidine derivatives
01/03/1996CN1030604C Methode for preparing of heterocyclic componds
01/02/1996US5481043 Phenone compounds, manufacturing method and pharmaceutical preparations containing them
01/02/1996US5481036 Renin inhibitors, hypotensive agents
01/02/1996US5481021 Phenyl amidines derivatives useful as platelet aggregation inhibitors
01/02/1996US5481000 Process for preparing chiral [[(2-bromoethyl)-amino]methyl]-2-nitro-1H-imidazol-1-ethanol and related compounds
01/02/1996US5480999 Containing an acid and an arginine analogue
01/02/1996US5480998 Oxime derivative
01/02/1996US5480997 Pyridine-substituted benzenemethanamine derivatives
01/02/1996US5480989 Carbamates of rapamycin
01/02/1996US5480988 Carbamates of rapamycin
01/02/1996US5480987 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them
01/02/1996US5480983 Adenosine derivatives, preparation methods and pharmaceutical compositions containing them
01/02/1996US5480972 Diagnosing, treating and preventing sensitivity; dna sequences
01/02/1996US5480913 Anti-androgen compounds
01/02/1996US5480912 Method of treating HIV-1 with α-substituted benzenemethanamine derivatives
01/02/1996US5480910 Chemical compounds
01/02/1996US5480909 Method for inhibiting generation of free-radicals
01/02/1996US5480906 Antitumor agents
01/02/1996US5480905 Benzodioxane derivatives
01/02/1996US5480904 Benzothiophene compound
01/02/1996US5480903 Administering compounds or salts with carriers to skin for treating dermatitis including psoriasis
01/02/1996US5480901 Method for reducing unwanted cellular adhesions
01/02/1996US5480900 Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma
01/02/1996US5480894 3-hydroxypyridin-4-one derivatives as chelating agents
01/02/1996US5480892 (N-phthalimidoalkyl)piperidines
01/02/1996US5480891 Method for treating diabetes mellitus
01/02/1996US5480889 Compositions and methods for promoting hair growth
01/02/1996US5480888 1,2-benzoisoselenazol-3-(2h)-(thi)one derivatives
01/02/1996US5480887 Protease inhibitors
01/02/1996US5480884 For treating neuropathies and myopathies
01/02/1996US5480883 Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
01/02/1996US5480882 Benzoxazinone and benzothiazinone derivatives having cardiovascular activity
01/02/1996US5480881 Treatment of disease with paf-acether antagonists and procedure determining their efficacy
01/02/1996US5480880 Penem derivatives
01/02/1996US5480879 Quinolonecarboxylic acids
01/02/1996US5480878 Method for treating prostatic hypertrophy with estradiol derivatives
01/02/1996US5480877 Wound healing agents for cells
01/02/1996US5480875 1-hydroxy-2-(imidazo(1,2a)pyridin-3-yl)ethane-1,1-bis (phosphonic acid)
01/02/1996US5480874 Phosphonic diester derivatives
01/02/1996US5480873 Arthritis
01/02/1996US5480660 Removal of proteins
01/02/1996US5480652 Effervescent pharmaceutical composition containing ibuprofen and its method of preparation
01/02/1996US5480651 Composition and method for treating nicotine craving in smoking cessation
01/02/1996US5480650 Programmed release tablets containing naproxen
01/02/1996US5480649 Procaterol-containing preparation for application to the skin
01/02/1996US5480648 Transdermal prostaglandin composition
01/02/1996US5480645 Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena
01/02/1996US5480644 Collagen for injection in anus
01/02/1996US5480639 Methods for isolating individual taxanes
01/02/1996US5480637 Alkylmethylsiloxane containing gels
01/02/1996CA2153083A1 Pharmaceutical compositions and a process for the preparation thereof
01/02/1996CA2152981A1 Method of attenuating lung capillary leak in a mammal
01/02/1996CA2152684A1 Aerosol delivery of midazolam
01/02/1996CA2086335C Pyridopyrazine derivatives for treating substance abuse and addiction
01/02/1996CA2053247C 5-aminocarbonyl-5h-dibenzo(a,d)cyclohepten-5, 10-imines for treatment of epilepsy and cocaine addiction
01/02/1996CA2032904C Blocking agents of edrf effect or formation for the treatment of shock
12/1995
12/31/1995CA2152765A1 Methods for treating a physiological disorder associated with beta amyloid peptide
12/30/1995CA2152878A1 Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
12/30/1995CA2152233A1 Oligonucleotides to inhibit the expression of isoprenyl protein transferases
12/30/1995CA2127037A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion
12/29/1995CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them
12/29/1995CA2152722A1 Process for the production of purines
12/29/1995CA2152321A1 Compositions for treatment of diabetic complications
12/28/1995WO1995035322A1 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors
12/28/1995WO1995035320A1 High-affinity melatonin receptors and uses thereof
12/28/1995WO1995035310A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
12/28/1995WO1995035309A1 New thrombin inhibitors, their preparation and use
12/28/1995WO1995035308A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
12/28/1995WO1995035304A1 Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
12/28/1995WO1995035303A1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
12/28/1995WO1995035302A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity
12/28/1995WO1995035300A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines
12/28/1995WO1995035297A1 Novel substituted purinyl derivatives with immunomodulating activity
12/28/1995WO1995035294A1 Protein kinase c inhibitors
12/28/1995WO1995035293A1 Indol derivatives useful for the treatment of migraine, composition and utilization
12/28/1995WO1995035292A1 Antiviral agent containing benzodithiin derivative as active ingredient